No trading action warranted. This is a routine administrative filing with no informational content for the stock. Monitor next quarterly earnings for fundamental developments.
Price Chart
Executive Summary
GSK filed a routine 6-K reporting that multiple PDMRs (including the CEO, CFO, and other senior executives) acquired ordinary shares and ADSs through the automatic reinvestment of dividends paid on July 9, 2026. The transactions are mechanical dividend reinvestments, not discretionary open-market purchases, and carry no signaling value. The filing is administrative and has no material impact on the company's financial outlook or stock price.
Key Facts
- Dividend reinvestment transactions occurred on July 9, 10, and 13, 2026.
- CEO Luke Miels acquired 20.727 ordinary shares at £19.6297 via dividend reinvestment.
- CFO Julie Brown increased notional interest by 1,636 ordinary shares at £19.5950 via the Deferred Annual Bonus Plan.
- President Corporate Development David Redfern acquired 5,803.725 ordinary shares at £19.6297 via dividend reinvestment.
- Chief Digital and Technology Officer Shobie Ramakrishnan increased notional interest by 324 ADSs at $52.47 via the Deferred Annual Bonus Plan.
- All transactions were automatic, not discretionary open-market purchases.
Financial Impact
No material financial impact. Total aggregate value of all reported transactions is approximately £250,000 (based on share counts and prices in the filing).
Risk Factors
- None from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006640 |
| Document: 0001654954-26-006640-index-headers.html | 0001654954-26-006640 |
| Document: 0001654954-26-006640-index.html | 0001654954-26-006640 |
| Document: 0001654954-26-006640.txt | 0001654954-26-006640 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access